Novo Nordisk (NVO)
(Delayed Data from NYSE)
$140.87 USD
-0.52 (-0.37%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $140.89 +0.02 (0.01%) 6:32 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Brokerage Reports
Novo Nordisk A/S [NVO]
Reports for Purchase
Showing records 181 - 196 ( 196 total )
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Medical - Drugs
4Q 09 Revenues and operating performance were in line with our expectations
Provider: IIR GROUP
Analyst: KHAN F